요약정보
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
- Resource Type
- Academic Journal
- Authors
- Thomas D; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; McDonald VM; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.; Stevens S; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Harvey ES; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.; Baraket M; South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.; Bardin P; Lung and Sleep Medicine, Monash University and Medical Centre and Hudson Institute, Clayton, Victoria, Australia.; Bowden JJ; Respiratory and Sleep Services, Flinders Medical Centre and Flinders University, Bedford Park, South Australia, Australia.; Bowler S; Department of Respiratory Medicine, Mater Hospital, Brisbane, Queensland, Australia.; Chien J; Department of Sleep and Respiratory Medicine, Westmead Hospital, Westmead, New South Wales, Australia.; School of Medicine, The University of Sydney, Sydney, New South Wales, Australia.; Chung LP; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; Gillman A; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.; Hew M; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Hodge S; Lung Research Laboratory, Hanson Institute, Adelaide, South Australia, Australia.; Department of Thoracic Medicine, Royal Adelaide Hospital, Lung Research, University of Adelaide, Adelaide, South Australia, Australia.; James A; Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Medcial School, The University of Western Australia, Perth, Western Australia, Australia.; Jenkins C; Department of Thoracic Medicine, Concord Hospital, Concord, New South Wales, Australia.; Concord Clinical School, University of Sydney, Concord, New South Wales, Australia.; Katelaris CH; School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.; Immunology and Allergy Unit, Campbelltown Hospital, Campbelltown, New South Wales, Australia.; Katsoulotos GP; Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.; The University of Notre Dame, Sydney, Western Australia, Australia.; St George Specialist Centre, Kogarah, New South Wales, Australia.; St Vincent's Clinic, Darlinghurst, New South Wales, Australia.; Langton D; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.; Department of Thoracic Medicine, Frankston Hospital, Frankston, Victoria, Australia.; Lee J; Austin Health, Melbourne, Victoria, Australia.; Marks G; South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.; Peters M; Department of Thoracic Medicine, Concord Hospital, Concord, New South Wales, Australia.; Radhakrishna N; Respiratory Department, St Vincent's Hospital, Melbourne, Victoria, Australia.; Reynolds PN; Department of Thoracic Medicine, Royal Adelaide Hospital, Lung Research, University of Adelaide, Adelaide, South Australia, Australia.; Rimmer J; Woolcock Institute of Medical Research, University of Sydney, Glebe, New South Wales, Australia.; St Vincent's Clinic, Darlinghurst, New South Wales, Australia.; Sivakumaran P; Department of Respiratory Medicine, Gold Coast University Hospital, Gold Coast, Queensland, Australia.; Upham JW; Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Wark P; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.; Yang IA; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.; Gibson PG; Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, University of Newcastle, Hunter Medical Research Institute Asthma and Breathing Programme, Newcastle, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
- Source
- Publisher:
Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN:01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE - Subject
- Language
- English